Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and intralipid for recurrent implantation failure
IRCT20240515061807N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Jan 2025
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma and Intralipid 10% in infertility and Recurrent Implantation Failure (RIF) (4 arms), sponsored by Islamic Azad University. Primary endpoint: Live birth. Started Jan 2025; status: completed.
02
Drugs
platelet-rich plasmaIntralipid 10%
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20240515061807N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240515061807N1.